Daily SPAC Update – July 31, 2025

by | Jul 31, 2025

75 New SPACs in 2025. Pompliano Changes Tickers for ProCap Bitcoin SPAC. Future Tech II Extension Set.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

JULY 2025 SPAC ISSUANCE
SPACs may not be back to peak times, but they are back. July saw another 12 SPAC IPOs for over $2B. This continues the elevated trend we’ve seen since the start of April, though remains off the peak of May. This makes a total of 75 new SPACs in 2025 for $15B in total new SPAC issuance. At the moment, the stars are the Crypto SPACs like Anthony Pompliano’s which today changes its ticker to BRR which represents “Bitcoin Rate of Return.”

SPAC IPO Issuance July 2025

SPAC DEAL & EXTENSION VOTES SET
FTII – Futuretech II Acquisition Corp * EXTENSION VOTE SET: Aug 14, 2025 * trust $12.53

OTHER SPAC NEWS
CCCM – COLUMBUS CIRCLE CAPITAL CORP I * Ticker Change
DYNX – DYNAMIX CORP * Media Transcript

SEPARATE WARRANTS/RIGHTS
Jul 31: BLUE WATER ACQUISITION CORP III (BLUW)

NEW SPAC IPOs
Jul 30: APAD – A Paradise Acquisition Corp. $200M IPO

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
6.97% ~ $ 28.86 | CEP – CANTOR EQUITY PARTNERS INC (Announced)
4.18% ~ $ 12.20 | ATMC – ALPHATIME ACQUISITION CORP (Announced)
1.79% ~ $ 10.80 | DYNX – DYNAMIX CORP (Announced)
.84% ~ $ 12.00 | SVII – SPRING VALLEY ACQUISITION CORP II (Pre-Deal)
.67% ~ $ 10.58 | SBXD – SILVERBOX CORP IV (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-11.55% ~ $ 10.11 | CHEB – CHENGHE ACQUISITION II CO (Announced)
-1.53% ~ $ 10.97 | CEPT – CANTOR EQUITY PARTNERS II INC (Pre-Deal)
-.85% ~ $ 10.51 | YORK – YORKVILLE ACQUISITION CORP (Pre-Deal)
-.69% ~ $ 10.04 | EGHA – EGH ACQUISITION CORP (Pre-Deal)
-.63% ~ $ 11.08 | CEPO – CANTOR EQUITY PARTNERS I INC (Announced)

LATEST SPAC IPO PERFORMANCE
Jul 30 | $ .00 | APAD – A Paradise Acquisition Corp.
Jul 17 | $ 10.03 | PAII – Pyrophyte Acquisition Corp. II
Jul 16 | $ 10.07 | SOCA – Solarius Capital Acquisition Corp.
Jul 15 | $ 10.11 | SPEG – Silver Pegasus Acquisition Corp.
Jul 09 | $ 10.20 | GTER – Globa Terra Acquisition Corporation
Jul 02 | $ 10.04 | ORIQ – Origin Investment Corp I
Jul 02 | $ 10.00 | VNME – Vendome Acquisition Corp I
Jul 02 | $ 10.50 | ONCH – 1RT Acquisition Corp.
Jul 02 | $ 10.10 | EVAC – EQV Ventures Acquisition Corp. II
Jul 01 | $ 10.08 | INAC – Indigo Acquisition Corp.
Jul 01 | $ 10.06 | NMP – NMP Acquisition Corp.
Jul 01 | $ 10.28 | CCII – Cohen Circle Aqusition Corp. II

Recent Analysis

Daily SPAC Update – May 4, 2026

Blueport + SingAuto and Galaxyedge + Rongcheng Group Deals announced late Friday. Pono Capital Four separate trading. Gigcapital 7 non-redemption agreement.

Weekly Boardroom & Executive Moves: May 1, 2026

This week, significant leadership changes occurred across several companies facing financial difficulties. Abbott Laboratories (ABT) and Agilon Health Inc (AGL) appointed new board members and executives amidst high activist risks and declining TSRs. Accuray Inc (ARAY) and ALT5 Sigma Corp (ALTS) also saw key executive departures and appointments as they navigate substantial TSR declines. These shifts highlight the ongoing challenges and strategic redirections needed to stabilize operations and improve shareholder value.

Daily SPAC Update – May 1, 2026

Two SPAC IPOs launched today, raising a total of $500 million. CH4 Natural Solutions Acquisition Corp (MTNE) secured $300 million, while Quantum Leap Acquisition Corp (QLEP) raised $200 million. Today, 2 SPAC IPOs raised $500M, led by CH4 Natural Solutions (MTNE) at $300M. This follows a surge of activity at the end of April.

Daily SPAC Update – April 30, 2026

Today, six SPACs debuted, raising a total of $965 million. General Catalyst Global Resilience Merger Corp (GCGR) led the pack with $350 million, followed by RRE Ventures Acquisition Corp. (RREV) at $250 million. Month-to-date, SPAC IPOs total 16, bringing in $2.65 billion, compared to 11 IPOs last month that raised $1.72 billion.

Daily SPAC Update – April 29, 2026

Collective Acquisition Corp. II (CAII) launched its $220 million IPO today, targeting high-potential sectors like technology and healthcare. In executive moves, Roger Bendelac was appointed CEO of both Drugs Made in America Acquisition Corp (DMAA) and Drugs Made in America Acquisition II Corp (DMII), with Saleem Elmasri as CFO. Meanwhile, General Purpose Acquisition Corp (GPAC) saw a significant decline of 22.9%, closing at $9.96, while Aimei Health Technology Co Ltd (AFJK) gained 2.7% to $46.12.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.